Although in a theory proposed by Fearon and Vogelstein in 1990, the adenomas progress to carcinomas in a sequential of events involving loss or mutation of APC, mutation of KRAS, and mutation of TP53, recent studies have shown that only 6.6% of CRC cases have mutations involving all these three driver genes [38]. The gene discussed is KRAS; the disease is colorectal carcinoma.